Clinical Trial: A Study to Find Out How Effective and Safe JNJ-88545223 is for the Treatment of Participants With Active Psoriatic Arthritis (a Long-term Inflammatory Arthritis)

U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07321873) titled 'A Study to Find Out How Effective and Safe JNJ-88545223 is for the Treatment of Participants With Active Psoriatic Arthritis (a Long-term Inflammatory Arthritis)' on Jan. 05.

Brief Summary: The purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA). The study aims to see whether treatment with JNJ-88545223 can help reduce the signs and symptoms of PsA and improve joint and skin health.

Study Start Date: Jan. 30

Study Type: INTERVENTIONAL

Condition: Arthritis, Psoriatic

Intervention: DRUG: JNJ-88545223

JNJ-88...